ICG Enterprise Trust plc
24 November 2022
ICG Enterprise Trust co-investing in AmeriLife
ICG Enterprise Trust plc (ICGT) is pleased to announce that it is investing in AmeriLife, alongside funds advised by ICGT’s Manager, ICG plc1 and THL, a leading US Private Equity Manager.
In aggregate, on a look-through basis, ICGT is expected to invest approximately $11.2m (£9.6m) in AmeriLife. This figure relates to ICGT’s look-through position in the overall investment in AmeriLife and is stated before any closing adjustments.
AmeriLife is a national leader in developing, marketing, distributing and administering life and health insurance products, annuities, and retirement planning solutions to senior citizens in the US. For nearly 50 years, AmeriLife has partnered with the US’ leading insurance carriers to service a national distribution network of over 300,000 insurance agents and advisors.
1 Intermediate Capital Group plc
Analyst / Investor enquiries: +44 (0) 20 3545 2000
Oliver Gardey, Head of Private Equity Fund Investments, ICG
Colm Walsh, Managing Director, ICG
Chris Hunt, Head of Shareholder Relations, ICG
Livia Bridgman Baker, Shareholder Relations, ICG
Clare Glynn, Corporate Communications, ICG: +44 (0) 20 3545 1395
About ICG Enterprise Trust
ICG Enterprise Trust is a leading listed private equity investor focused on creating long-term growth by delivering consistently strong returns through selectively investing in profitable private companies, primarily in Europe and the US.
As a listed private equity investor, our purpose is to provide shareholders with access to the attractive long-term returns generated by investing in private companies, with the added benefit of daily liquidity.
We invest in companies directly and through funds managed by ICG and other leading private equity managers who focus on creating long-term value and building sustainable growth through active management and strategic change.
We have a long track record of delivering strong returns through a flexible mandate and highly selective approach that strikes the right balance between concentration and diversification, risk and reward.
This report may contain forward looking statements. These written materials are not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended, or an exemption therefrom. The issuer has not and does not intend to register any securities under the US Securities Act of 1933, as amended, and does not intend to offer any securities to the public in the United States. No money, securities or other consideration from any person inside the United States is being solicited and, if sent in response to the information contained in these written materials, will not be accepted.
Although this investment does not amount to price sensitive material information, ICG Enterprise Trust is making this information public on an illustrative basis to aid with market understanding of our portfolio. Similar announcements may be made in respect of future non-material investments.